These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5574520)

  • 1. Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions.
    Mendell JR; Engel WK; Derrer EC
    Science; 1971 Jun; 172(3988):1143-5. PubMed ID: 5574520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma enzyme concentrations in rats with functional ischaemia of muscle provide a possible model of Duchenne muscular dystrophy.
    Mendell JR; Engel WK; Derrer EC
    Nature; 1972 Oct; 239(5374):522-4. PubMed ID: 4563024
    [No Abstract]   [Full Text] [Related]  

  • 3. Focal lesions of muscle in peripheral vascular disease.
    Engel WK; Hawley RJ
    J Neurol; 1977 Jun; 215(3):161-8. PubMed ID: 69685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle.
    Musch BC; Papapetropoulos TA; McQueen DA; Hudgson P; Weightman D
    J Neurol Sci; 1975 Oct; 26(2):221-34. PubMed ID: 1176989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Serotonin-induced electrical silence of rat skeletal muscle with experimentally induced Duchenne muscular dystrophy.
    Pohlman A; Prabhu VG
    J Am Osteopath Assoc; 1976 Jan; 75(5):530. PubMed ID: 1044318
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure to confirm a vascular cause of muscular dystrophy.
    Bradley WG; O'Brien MD; Walder DN; Murchison D; Johnson M; Newell DJ
    Arch Neurol; 1975 Jul; 32(7):466-73. PubMed ID: 1137513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental serotonin myopathy.
    Munsat TL; Hudgson P; Johnson MA
    Neurology; 1977 Aug; 27(8):772-82. PubMed ID: 560648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood vessel structure in Duchenne muscular dystrophy. I. Light and electron microscopic observations in resting muscle.
    Koehler J
    Neurology; 1977 Sep; 27(9):861-8. PubMed ID: 561343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pargyline-induced myopathy with histochemical characteristics of Duchenne muscular dystrophy.
    Yu MK; Wright TL; Dettbarn WD; Olson WH
    Neurology; 1974 Mar; 24(3):237-44. PubMed ID: 4273288
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.
    Asai A; Sahani N; Kaneki M; Ouchi Y; Martyn JA; Yasuhara SE
    PLoS One; 2007 Aug; 2(8):e806. PubMed ID: 17726536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne dystrophy viewed as a disturbance of nerve-muscle interactions.
    Vrbova G
    Muscle Nerve; 1983; 6(9):671-5. PubMed ID: 6361549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber.
    Mokri B; Engel AG
    Neurology; 1975 Dec; 25(12):1111-20. PubMed ID: 1105232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
    Miike T
    Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle fiber immaturity and inactivity reduce myonecrosis in Duchenne muscular dystrophy.
    Kimura S; Sugino S; Ohtani Y; Matsukura M; Nishino I; Ikezawa M; Sakata A; Kondo Y; Yoshioka K; Huard J; Nonaka I; Miike T
    Ann Neurol; 1998 Dec; 44(6):967-71. PubMed ID: 9851444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy: assessment of experimental data from animals in relation to the human disease.
    Elbrink J; Malhotra SK; Hunter EG
    Med Hypotheses; 1987 Jun; 23(2):131-6. PubMed ID: 3614006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathogenesis of Duchenne muscular dystrophy--defects of the membrane cytoskeleton "dystrophin"].
    Arahata K; Sugita H
    Nihon Rinsho; 1989 Aug; 47(8):1857-64. PubMed ID: 2685400
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinction between Duchenne and other muscular dystrophies by ribosomal protein synthesis.
    Ionasescu V
    J Med Genet; 1975 Mar; 12(1):49-54. PubMed ID: 164552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are hypercontracted muscle fibers artifacts and do they cause rupture of the plasma membrane?
    Lotz BP; Engel AG
    Neurology; 1987 Sep; 37(9):1466-75. PubMed ID: 3627448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations about a possible role played by connective tissue proliferation and vascular disturbances in the pathogenesis of progressive muscular dystrophy.
    Cazzato G
    Eur Neurol; 1968; 1(3):158-79. PubMed ID: 5698619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.